Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
[Not Available].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Tegn N, Abdelnoor M, Aaberge L, Endresen K, Gullestad L, Bendz B.
PMID: 27637033
Tidsskr Nor Laegeforen. 2016 Sep 13;136(16):1324-5. doi: 10.4045/tidsskr.16.0685. eCollection 2016 Sep.

No abstract available.

Cite
Tegn N, Abdelnoor M, Aaberge L, et al. Re: Over 80 år og hjerteinfarkt. [Not Available]. Tidsskr Nor Laegeforen. 2016;136(16):1324-5doi: 10.4045/tidsskr.16.0685.
Tegn, N., Abdelnoor, M., Aaberge, L., Endresen, K., Gullestad, L., & Bendz, B. (2016). Re: Over 80 år og hjerteinfarkt. [Not Available]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 136(16), 1324-5. https://doi.org/10.4045/tidsskr.16.0685
Tegn, Nicolai, et al. "Re: Over 80 år og hjerteinfarkt." [Not Available]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 136,16 (2016): 1324-5. doi: https://doi.org/10.4045/tidsskr.16.0685
Tegn N, Abdelnoor M, Aaberge L, Endresen K, Gullestad L, Bendz B. Re: Over 80 år og hjerteinfarkt. [Not Available]. Tidsskr Nor Laegeforen. 2016 Sep 13;136(16):1324-5. doi: 10.4045/tidsskr.16.0685. eCollection 2016 Sep. Norwegian. PMID: 27637033.
Copy Download .nbib Format: NLM
Sleep-disordered Breathing in Heart Failure - Current State of the Art.

Cardiac failure review

Cowie MR, Woehrle H, Oldenburg O, Damy T, van der Meer P, Erdman E, Metra M, Zannad F, Trochu JN, Gullestad L, Fu M, Böhm M, Auricchio A, Levy P.
PMID: 28785426
Card Fail Rev. 2015 Apr;1(1):16-24. doi: 10.15420/cfr.2015.01.01.16.

Sleep-disordered breathing (SDB), either obstructive sleep apnoea (OSA) or central sleep apnoea (CSA)/Cheyne-Stokes respiration (CSR) and often a combination of the two, is highly prevalent in patients with heart failure (HF), is associated with reduced functional capacity and quality...

Cite
Cowie MR, Woehrle H, Oldenburg O, et al. Sleep-disordered Breathing in Heart Failure - Current State of the Art. Card Fail Rev. 2015;1(1):16-24doi: 10.15420/cfr.2015.01.01.16.
Cowie, M. R., Woehrle, H., Oldenburg, O., Damy, T., van der Meer, P., Erdman, E., Metra, M., Zannad, F., Trochu, J. N., Gullestad, L., Fu, M., Böhm, M., Auricchio, A., & Levy, P. (2015). Sleep-disordered Breathing in Heart Failure - Current State of the Art. Cardiac failure review, 1(1), 16-24. https://doi.org/10.15420/cfr.2015.01.01.16
Cowie, Martin R, et al. "Sleep-disordered Breathing in Heart Failure - Current State of the Art." Cardiac failure review vol. 1,1 (2015): 16-24. doi: https://doi.org/10.15420/cfr.2015.01.01.16
Cowie MR, Woehrle H, Oldenburg O, Damy T, van der Meer P, Erdman E, Metra M, Zannad F, Trochu JN, Gullestad L, Fu M, Böhm M, Auricchio A, Levy P. Sleep-disordered Breathing in Heart Failure - Current State of the Art. Card Fail Rev. 2015 Apr;1(1):16-24. doi: 10.15420/cfr.2015.01.01.16. PMID: 28785426; PMCID: PMC5491026.
Copy Download .nbib Format: NLM
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?.

European journal of preventive cardiology

Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J.
PMID: 33611511
Eur J Prev Cardiol. 2020 May 13; doi: 10.1177/2047487320923187. Epub 2020 May 13.

No abstract available.

Cite
Munkhaugen J, Sverre E, Peersen K, et al. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020;doi: 10.1177/2047487320923187.
Munkhaugen, J., Sverre, E., Peersen, K., Kristiansen, O., Gjertsen, E., Gullestad, L., & Erik Otterstad, J. (2020). Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. European journal of preventive cardiology, . https://doi.org/10.1177/2047487320923187
Munkhaugen, John, et al. "Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?." European journal of preventive cardiology vol. (2020). doi: https://doi.org/10.1177/2047487320923187
Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020 May 13; doi: 10.1177/2047487320923187. Epub 2020 May 13. PMID: 33611511.
Copy Download .nbib Format: NLM
Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Brautaset Englund KV, Østby CM, Rolid K, Gude E, Andreassen AK, Gullestad L, Broch K.
PMID: 33612360
J Heart Lung Transplant. 2021 May;40(5):359-367. doi: 10.1016/j.healun.2021.01.1390. Epub 2021 Jan 23.

AIMS: Heart transplant recipients have reduced exercise capacity despite preserved graft function. The IronIC trial was designed to test the hypothesis that intravenous iron therapy would improve peak oxygen consumption in these patients.METHODS AND RESULTS: This randomized, placebo-controlled, double-blind...

Cite
Brautaset Englund KV, Østby CM, Rolid K, et al. Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial. J Heart Lung Transplant. 2021;40(5):359-367doi: 10.1016/j.healun.2021.01.1390.
Brautaset Englund, K. V., Østby, C. M., Rolid, K., Gude, E., Andreassen, A. K., Gullestad, L., & Broch, K. (2021). Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 40(5), 359-367. https://doi.org/10.1016/j.healun.2021.01.1390
Brautaset Englund, Kristine V, et al. "Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 40,5 (2021): 359-367. doi: https://doi.org/10.1016/j.healun.2021.01.1390
Brautaset Englund KV, Østby CM, Rolid K, Gude E, Andreassen AK, Gullestad L, Broch K. Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial. J Heart Lung Transplant. 2021 May;40(5):359-367. doi: 10.1016/j.healun.2021.01.1390. Epub 2021 Jan 23. PMID: 33612360.
Copy Download .nbib Format: NLM
Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis.

Open heart

Kvaslerud AB, Hussain AI, Auensen A, Ueland T, Michelsen AE, Pettersen KI, Aukrust P, Mørkrid L, Gullestad L, Broch K.
PMID: 30613413
Open Heart. 2018 Dec 16;5(2):e000901. doi: 10.1136/openhrt-2018-000901. eCollection 2018.

OBJECTIVE: The aim of this study was to evaluate the prevalence and prognostic implication of iron deficiency (ID) and anaemia in patients with severe aortic stenosis (AS).METHODS: In an observational study of consecutive patients referred for aortic valve replacement...

Cite
Kvaslerud AB, Hussain AI, Auensen A, et al. Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. Open Heart. 2018;5(2):e000901doi: 10.1136/openhrt-2018-000901.
Kvaslerud, A. B., Hussain, A. I., Auensen, A., Ueland, T., Michelsen, A. E., Pettersen, K. I., Aukrust, P., Mørkrid, L., Gullestad, L., & Broch, K. (2018). Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. Open heart, 5(2), e000901. https://doi.org/10.1136/openhrt-2018-000901
Kvaslerud, Anette Borger, et al. "Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis." Open heart vol. 5,2 (2018): e000901. doi: https://doi.org/10.1136/openhrt-2018-000901
Kvaslerud AB, Hussain AI, Auensen A, Ueland T, Michelsen AE, Pettersen KI, Aukrust P, Mørkrid L, Gullestad L, Broch K. Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. Open Heart. 2018 Dec 16;5(2):e000901. doi: 10.1136/openhrt-2018-000901. eCollection 2018. PMID: 30613413; PMCID: PMC6307621.
Copy Download .nbib Format: NLM
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.

Translational oncology

Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM.
PMID: 31096111
Transl Oncol. 2019 Jul;12(7):951-958. doi: 10.1016/j.tranon.2019.04.001. Epub 2019 May 13.

Although clinical management of melanoma has changed considerably in recent years, intrinsic treatment resistance remains a severe problem and strategies to design personal treatment regimens are highly warranted. We have applied a three-dimensional (3D) ex vivo drug efficacy assay,...

Cite
Flørenes VA, Flem-Karlsen K, McFadden E, et al. A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases. Transl Oncol. 2019;12(7):951-958doi: 10.1016/j.tranon.2019.04.001.
Flørenes, V. A., Flem-Karlsen, K., McFadden, E., Bergheim, I. R., Nygaard, V., Nygård, V., Farstad, I. N., Øy, G. F., Emilsen, E., Giller-Fleten, K., Ree, A. H., Flatmark, K., Gullestad, H. P., Hermann, R., Ryder, T., Wernhoff, P., & Mælandsmo, G. M. (2019). A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases. Translational oncology, 12(7), 951-958. https://doi.org/10.1016/j.tranon.2019.04.001
Flørenes, Vivi Ann, et al. "A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases." Translational oncology vol. 12,7 (2019): 951-958. doi: https://doi.org/10.1016/j.tranon.2019.04.001
Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM. A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases. Transl Oncol. 2019 Jul;12(7):951-958. doi: 10.1016/j.tranon.2019.04.001. Epub 2019 May 13. PMID: 31096111; PMCID: PMC6520638.
Copy Download .nbib Format: NLM
Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation.

Journal of the American College of Cardiology

Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF.
PMID: 34886963
J Am Coll Cardiol. 2021 Dec 14;78(24):2425-2435. doi: 10.1016/j.jacc.2021.10.009.

BACKGROUND: Single-center data suggest that the index of microcirculatory resistance (IMR) measured early after heart transplantation predicts subsequent acute rejection.OBJECTIVES: The goal of this study was to validate whether IMR measured early after transplantation can predict subsequent acute rejection...

Cite
Ahn JM, Zimmermann FM, Gullestad L, et al. Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. J Am Coll Cardiol. 2021;78(24):2425-2435doi: 10.1016/j.jacc.2021.10.009.
Ahn, J. M., Zimmermann, F. M., Gullestad, L., Angerås, O., Karason, K., Russell, K., Lunde, K., Okada, K., Luikart, H., Khush, K. K., Honda, Y., Pijls, N. H. J., Lee, S. E., Kim, J. J., Park, S. J., Solberg, O. G., & Fearon, W. F. (2021). Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. Journal of the American College of Cardiology, 78(24), 2425-2435. https://doi.org/10.1016/j.jacc.2021.10.009
Ahn, Jung-Min, et al. "Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation." Journal of the American College of Cardiology vol. 78,24 (2021): 2425-2435. doi: https://doi.org/10.1016/j.jacc.2021.10.009
Ahn JM, Zimmermann FM, Gullestad L, Angerås O, Karason K, Russell K, Lunde K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Solberg OG, Fearon WF. Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart Transplantation. J Am Coll Cardiol. 2021 Dec 14;78(24):2425-2435. doi: 10.1016/j.jacc.2021.10.009. PMID: 34886963.
Copy Download .nbib Format: NLM
Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?.

European journal of preventive cardiology

Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J.
PMID: 32397790
Eur J Prev Cardiol. 2020 May 12;2047487320923187. doi: 10.1177/2047487320923187. Epub 2020 May 12.

No abstract available.

Cite
Munkhaugen J, Sverre E, Peersen K, et al. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020;2047487320923187doi: 10.1177/2047487320923187.
Munkhaugen, J., Sverre, E., Peersen, K., Kristiansen, O., Gjertsen, E., Gullestad, L., & Erik Otterstad, J. (2020). Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. European journal of preventive cardiology, 2047487320923187. https://doi.org/10.1177/2047487320923187
Munkhaugen, John, et al. "Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?." European journal of preventive cardiology vol. (2020): 2047487320923187. doi: https://doi.org/10.1177/2047487320923187
Munkhaugen J, Sverre E, Peersen K, Kristiansen O, Gjertsen E, Gullestad L, Erik Otterstad J. Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. Eur J Prev Cardiol. 2020 May 12;2047487320923187. doi: 10.1177/2047487320923187. Epub 2020 May 12. PMID: 32397790.
Copy Download .nbib Format: NLM
Noni (.

Frontiers in genetics

Rajaei-Sharifabadi H, Ellestad L, Porter T, Donoghue A, Bottje WG, Dridi S.
PMID: 29259622
Front Genet. 2017 Dec 05;8:192. doi: 10.3389/fgene.2017.00192. eCollection 2017.

Heat stress (HS) adversely affects growth performance and inflicts heavy economic losses to the poultry industry. There is, therefore, a critical need to identify new alternative strategies to alleviate the negative effects induced by HS. The tropic medicinal plant,

Cite
Rajaei-Sharifabadi H, Ellestad L, Porter T, et al. Noni (. Front Genet. 2017;8:192doi: 10.3389/fgene.2017.00192.
Rajaei-Sharifabadi, H., Ellestad, L., Porter, T., Donoghue, A., Bottje, W. G., & Dridi, S. (2017). Noni (. Frontiers in genetics, 8192. https://doi.org/10.3389/fgene.2017.00192
Rajaei-Sharifabadi, Hossein, et al. "Noni (." Frontiers in genetics vol. 8 (2017): 192. doi: https://doi.org/10.3389/fgene.2017.00192
Rajaei-Sharifabadi H, Ellestad L, Porter T, Donoghue A, Bottje WG, Dridi S. Noni (. Front Genet. 2017 Dec 05;8:192. doi: 10.3389/fgene.2017.00192. eCollection 2017. PMID: 29259622; PMCID: PMC5723331.
Copy Download .nbib Format: NLM
Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients.

Transplantation research

Robertsen I, Falck P, Andreassen AK, Næss NK, Lunder N, Christensen H, Gullestad L, Asberg A.
PMID: 23566530
Transplant Res. 2013 Apr 08;2(1):5. doi: 10.1186/2047-1440-2-5.

BACKGROUND: In the early phases following heart transplantation a main challenge is to reduce the impact of acute rejections. Previous studies indicate that intracellular ciclosporin A (CsA) concentration may be a sensitive acute rejection marker in renal transplant recipients....

Cite
Robertsen I, Falck P, Andreassen AK, et al. Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients. Transplant Res. 2013;2(1):5doi: 10.1186/2047-1440-2-5.
Robertsen, I., Falck, P., Andreassen, A. K., Næss, N. K., Lunder, N., Christensen, H., Gullestad, L., & Asberg, A. (2013). Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients. Transplantation research, 2(1), 5. https://doi.org/10.1186/2047-1440-2-5
Robertsen, Ida, et al. "Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients." Transplantation research vol. 2,1 (2013): 5. doi: https://doi.org/10.1186/2047-1440-2-5
Robertsen I, Falck P, Andreassen AK, Næss NK, Lunder N, Christensen H, Gullestad L, Asberg A. Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients. Transplant Res. 2013 Apr 08;2(1):5. doi: 10.1186/2047-1440-2-5. PMID: 23566530; PMCID: PMC3643826.
Copy Download .nbib Format: NLM
Erratum: Transcription and replication result in distinct epigenetic marks following repression of early gene expression.

Frontiers in genetics

Milavetz B, Kallestad L, Woods E, Christensen K, Gefroh A, Balakrishnan L.
PMID: 24348514
Front Genet. 2013 Dec 02;4:259. doi: 10.3389/fgene.2013.00259.

No abstract available.

Cite
Milavetz B, Kallestad L, Woods E, et al. Erratum: Transcription and replication result in distinct epigenetic marks following repression of early gene expression. Front Genet. 2013;4:259doi: 10.3389/fgene.2013.00259.
Milavetz, B., Kallestad, L., Woods, E., Christensen, K., Gefroh, A., & Balakrishnan, L. (2013). Erratum: Transcription and replication result in distinct epigenetic marks following repression of early gene expression. Frontiers in genetics, 4259. https://doi.org/10.3389/fgene.2013.00259
Milavetz, Barry, et al. "Erratum: Transcription and replication result in distinct epigenetic marks following repression of early gene expression." Frontiers in genetics vol. 4 (2013): 259. doi: https://doi.org/10.3389/fgene.2013.00259
Milavetz B, Kallestad L, Woods E, Christensen K, Gefroh A, Balakrishnan L. Erratum: Transcription and replication result in distinct epigenetic marks following repression of early gene expression. Front Genet. 2013 Dec 02;4:259. doi: 10.3389/fgene.2013.00259. PMID: 24348514; PMCID: PMC3845208.
Copy Download .nbib Format: NLM
The otherness of sexuality: Exploring the conflicted nature of drive, desire and object choice.

The International journal of psycho-analysis

Gullestad SE.
PMID: 33952026
Int J Psychoanal. 2020 Feb;101(1):64-83. doi: 10.1080/00207578.2019.1686390.

This article explores how the psychoanalytic drive theories of Freud, Laplanche and Lacan elucidate the conflicted nature of desire and object choice. In a close reading of Freud's

Cite
Gullestad SE. The otherness of sexuality: Exploring the conflicted nature of drive, desire and object choice. Int J Psychoanal. 2020;101(1):64-83doi: 10.1080/00207578.2019.1686390.
Gullestad, S. E. (2020). The otherness of sexuality: Exploring the conflicted nature of drive, desire and object choice. The International journal of psycho-analysis, 101(1), 64-83. https://doi.org/10.1080/00207578.2019.1686390
Gullestad, Siri Erika. "The otherness of sexuality: Exploring the conflicted nature of drive, desire and object choice." The International journal of psycho-analysis vol. 101,1 (2020): 64-83. doi: https://doi.org/10.1080/00207578.2019.1686390
Gullestad SE. The otherness of sexuality: Exploring the conflicted nature of drive, desire and object choice. Int J Psychoanal. 2020 Feb;101(1):64-83. doi: 10.1080/00207578.2019.1686390. PMID: 33952026.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries